Related Experiment Videos
HLA and Kaposi's sarcoma in solid organ transplantation
M E Brunson1, K Balakrishnan, I Penn
1Department of Surgery, University Cincinnati College of Medicine, Ohio.
Abstract:
Of 188 cases of Kaposi's sarcoma arising de novo after transplantation, HLA-A, -B typing was available for 135 and HLA-DR typing available for 67. Compared to the reported HLA phenotype frequencies of renal transplant recipients in the Southeast Organ Procurement Foundation (SEOPF), there is a significantly decreased frequency of HLA-A1 and HLA-B7, and increased frequency of HLA-B5, -B8, -B18, and -DR5. The most striking characteristic of the Kaposi's sarcoma group was its ethnic background. Fifty-six percent of patients were Italian, Greek, Jewish, or Arabic. When this ethnic background is considered, the expected HLA phenotype frequencies are almost exactly the same as in the Kaposi's sarcoma population. The quality of donor-recipient HLA match was evaluable for 106 patients. Only 22% had four or more mismatches, and 59% had at least two antigens matched. This argues against poor donor-recipient matching as a risk factor for developing Kaposi's sarcoma after transplantation.
Insights
Kaposi
Area of Science:
- Immunogenetics
- Transplantation Immunology
- Oncology
Background:
- Kaposi's sarcoma (KS) is a malignancy that can arise de novo after organ transplantation.
- The role of human leukocyte antigen (HLA) matching in post-transplant KS development requires further investigation.
- Previous studies suggest a potential link between specific HLA types and KS risk.
Purpose of the Study:
- To investigate the association between HLA phenotypes and the risk of developing de novo Kaposi's sarcoma after transplantation.
- To evaluate the impact of donor-recipient HLA matching quality on KS development.
Main Methods:
- Retrospective analysis of 188 de novo Kaposi's sarcoma cases post-transplantation.
- HLA-A, -B, and -DR typing data analyzed.
- Comparison of HLA phenotype frequencies with reported renal transplant recipient data and ethnic background considerations.
- Assessment of donor-recipient HLA mismatches in a subset of patients.
Main Results:
- Significantly decreased frequencies of HLA-A1 and HLA-B7, and increased frequencies of HLA-B5, -B8, -B18, and -DR5 observed in KS patients compared to general transplant recipients.
- The striking ethnic background of KS patients (56% Italian, Greek, Jewish, or Arabic) explained the observed HLA phenotype frequencies.
- Donor-recipient HLA matching quality did not appear to be a significant risk factor; only 22% had ≥4 mismatches, and 59% had ≥2 antigens matched.
Conclusions:
- The observed HLA associations with Kaposi's sarcoma post-transplantation are largely attributable to the specific ethnic background of the affected patient population.
- Poor donor-recipient HLA matching is unlikely to be a primary risk factor for developing Kaposi's sarcoma after transplantation.
- Further research into genetic predisposition and other risk factors beyond HLA matching is warranted.